Sierra Oncology Inc (NASDAQ:SRRA)

0.653
Delayed Data
As of Jun 19
 +0.0046 / +0.71%
Today’s Change
0.61
Today|||52-Week Range
3.70
-50.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization111.0K197.0K258.0K111.0K
 
 
 
 
 
 
Operating ExpensesGross Income-111.0K-197.0K-258.0K-111.0K
 
 
 
 
 
General Expenses35.7M45.2M42.3M55.2M
 
 
 
 
 
Research And Development26.4M31.6M30.1M41.0M
 
 
 
 
 
Total Operating Expenses35.8M45.4M42.6M55.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.8M-45.4M-42.6M-55.3M
 
 
 
 
 
Extraordinary Charge-17.5M-2.7M-69.0K-99.0K
 
 
 
 
 
Other Expenses76.0K351.0K760.0K1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.2M-47.7M-41.9M-53.6M
 
 
 
 
 
Income Taxes-55.0K-143.0K-156.0K-302.0K
 
 
 
 
 
Preferred Dividend-399.9M0.000.000.00
 
 
Net Income-53.3M-47.9M-42.0M-53.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.4M30.2M49.9M70.7M
 
 
 
 
 
Shares To Calculate EPS Diluted14.4M30.2M49.9M70.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$31.47-$1.58-$0.84-$0.75
 
 
 
 
 
EPS Diluted-$31.47-$1.58-$0.84-$0.75